FI941377A0 - Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja - Google Patents

Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja

Info

Publication number
FI941377A0
FI941377A0 FI941377A FI941377A FI941377A0 FI 941377 A0 FI941377 A0 FI 941377A0 FI 941377 A FI941377 A FI 941377A FI 941377 A FI941377 A FI 941377A FI 941377 A0 FI941377 A0 FI 941377A0
Authority
FI
Finland
Prior art keywords
pct
pyrazines
neuroleptic
pyrido
substituted perhydro
Prior art date
Application number
FI941377A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941377A (fi
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Teresa Annette Smolarek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941377A publication Critical patent/FI941377A/fi
Publication of FI941377A0 publication Critical patent/FI941377A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
FI941377A 1991-09-25 1994-03-24 Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja FI941377A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25
PCT/US1992/006625 WO1993006101A1 (en) 1991-09-25 1992-08-14 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2a]PYRAZINES

Publications (2)

Publication Number Publication Date
FI941377A FI941377A (fi) 1994-03-24
FI941377A0 true FI941377A0 (fi) 1994-03-24

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941377A FI941377A0 (fi) 1991-09-25 1994-03-24 Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja

Country Status (25)

Country Link
US (1) US5565453A (hu)
EP (1) EP0607163B1 (hu)
JP (1) JPH08827B2 (hu)
CN (1) CN1071167A (hu)
AT (1) ATE146178T1 (hu)
AU (1) AU655071B2 (hu)
BR (1) BR9206541A (hu)
CA (1) CA2118936A1 (hu)
CZ (1) CZ281775B6 (hu)
DE (1) DE69215886T2 (hu)
DK (1) DK0607163T3 (hu)
ES (1) ES2096099T3 (hu)
FI (1) FI941377A0 (hu)
GR (1) GR3022483T3 (hu)
HU (1) HUT71488A (hu)
IL (1) IL103204A (hu)
MX (1) MX9205385A (hu)
MY (1) MY108303A (hu)
NO (1) NO941084D0 (hu)
NZ (1) NZ244473A (hu)
PL (1) PL170889B1 (hu)
PT (1) PT100891A (hu)
TW (1) TW215090B (hu)
WO (1) WO1993006101A1 (hu)
ZA (1) ZA927306B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
DE69524241T2 (de) * 1994-09-30 2002-06-13 Pfizer Inc., New York 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
CN100389115C (zh) * 2003-03-12 2008-05-21 辉瑞产品公司 吡啶氧基甲基和苯并异唑氮杂二环衍生物
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
WO2014096212A1 (en) * 2012-12-20 2014-06-26 Janssen Pharmaceutica Nv NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
KR102171710B1 (ko) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
BR9206541A (pt) 1995-04-25
HU9400851D0 (en) 1994-06-28
PL170889B1 (pl) 1997-02-28
US5565453A (en) 1996-10-15
DK0607163T3 (da) 1997-03-17
MY108303A (en) 1996-09-30
ZA927306B (en) 1994-03-24
AU655071B2 (en) 1994-12-01
EP0607163B1 (en) 1996-12-11
NO941084L (no) 1994-03-24
HUT71488A (en) 1995-11-28
DE69215886T2 (de) 1997-04-03
ES2096099T3 (es) 1997-03-01
CN1071167A (zh) 1993-04-21
ATE146178T1 (de) 1996-12-15
NO941084D0 (no) 1994-03-24
EP0607163A1 (en) 1994-07-27
JPH06506701A (ja) 1994-07-28
IL103204A0 (en) 1993-02-21
WO1993006101A1 (en) 1993-04-01
FI941377A (fi) 1994-03-24
TW215090B (hu) 1993-10-21
CZ281775B6 (cs) 1997-01-15
MX9205385A (es) 1993-03-01
CZ395792A3 (en) 1994-05-18
CA2118936A1 (en) 1993-04-01
NZ244473A (en) 1995-04-27
PT100891A (pt) 1993-10-29
DE69215886D1 (de) 1997-01-23
IL103204A (en) 1996-05-14
JPH08827B2 (ja) 1996-01-10
AU2460992A (en) 1993-04-27
GR3022483T3 (en) 1997-05-31

Similar Documents

Publication Publication Date Title
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ZA918044B (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines of piperazines,and compositions and methods of use thereof
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
DK0607163T3 (da) Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner
ES8300729A1 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
DK0641346T3 (da) Antibiotiske 7-aminonaphthazarinderivater
EP0509098A4 (en) Ataractic
ZA828877B (en) Therapeutically useful 3,7a-diazacyclohepta(j,k)fluorene derivatives
FI990433A0 (fi) Neuroleptisiä perhydro-1H-pyrido(1,2-a)pyratsiineja
YU104092A (sh) NEUROLEPTIČNI 2-SUPSTITUISANI PERHIDRO-1-H-PIRIDO(1,2-a) PIRAZINI
GB9022046D0 (en) New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
FD Application lapsed